NextCure And Simcere Zaiming Announce Initiation Of Dose Optimization Portion Of Phase 1 Study Of SIM0505, Focusing On Patients With Platinum-Resistant Ovarian Cancer

Benzinga Newsdesk www.benzinga.com Neutral 57.8%

Neg 0% Neu 57.8% Pos 0%

Comments

No comments yet. Be the first!